| Jasmyne Avery, CRNA | |
|
2300 Opitz Blvd, Woodbridge, VA 22191-3311 | |
| (770) 643-5619 | |
| Not Available |
| Full Name | Jasmyne Avery |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 3 Years |
| Location | 2300 Opitz Blvd, Woodbridge, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619630290 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Potomac Anesthesia Consultants Llc | 7416343728 | 16 |
| Johns Hopkins University | 8921903147 | 2692 |
| Bestgate Anesthesia Llc | 9739309766 | 14 |
News Archive
MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
Eaton Scientific Systems, Ltd. a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to highlight the increasing international potential of Tropine 3 for the non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal women experiencing hot flashes.
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial indicating that ACE-031 was safe and well-tolerated at all dose levels and increased lean body mass.
› Verified 9 days ago
| Entity Name | North American Partners In Anesthesia Maryland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093707879 PECOS PAC ID: 1850283144 Enrollment ID: O20140317000783 |
News Archive
MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
Eaton Scientific Systems, Ltd. a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to highlight the increasing international potential of Tropine 3 for the non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal women experiencing hot flashes.
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial indicating that ACE-031 was safe and well-tolerated at all dose levels and increased lean body mass.
› Verified 9 days ago
| Entity Name | Potomac Anesthesia Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225781297 PECOS PAC ID: 7416343728 Enrollment ID: O20220413000036 |
News Archive
MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
Eaton Scientific Systems, Ltd. a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to highlight the increasing international potential of Tropine 3 for the non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal women experiencing hot flashes.
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial indicating that ACE-031 was safe and well-tolerated at all dose levels and increased lean body mass.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jasmyne Avery, CRNA 1814 Lorgnette Ct, Severn, MD 21144-1635 Ph: (619) 618-5854 | Jasmyne Avery, CRNA 2300 Opitz Blvd, Woodbridge, VA 22191-3311 Ph: (770) 643-5619 |
News Archive
MedCath Corporation and its physician partners announced today that they have entered into a definitive agreement to sell substantially all the assets of Heart Hospital of Austin to St. David's Healthcare Partnership, L.P. ("St. David's"). The transaction is expected to close during MedCath's third fiscal quarter of 2010, subject to customary closing conditions and regulatory requirements.
Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the publication in Science of research describing novel molecules designed to treat or prevent infection by the virus that causes COVID-19, SARS-CoV-2.
Eaton Scientific Systems, Ltd. a wholly-owned subsidiary of Pristine Solutions, Inc. is pleased to highlight the increasing international potential of Tropine 3 for the non-hormonal treatment for pre-menopausal, peri-menopausal, and post-menopausal women experiencing hot flashes.
Researchers from Uppsala University have studied beta cells of type-2 diabetic donors, and find that a mislocalized calcium channel contributes to the failed insulin secretion associated with the disease.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, and muscle, today announced preliminary results from the ACE-031 Phase 1 single dose clinical trial indicating that ACE-031 was safe and well-tolerated at all dose levels and increased lean body mass.
› Verified 9 days ago
Dorothy Lorraine Shackleford, Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 3963 Hartlake St, Woodbridge, VA 22192 Phone: 703-590-2019 | |
Robyn Camille Ward, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-583-3087 | |
Mrs. Jennifer Schmid Hooper, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-523-1000 | |
Claire Caine Garvey, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2300 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-523-1000 | |
Steven Paul Kelsch, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2300 Opiz Blvd., Woodbridge, VA 22191 Phone: 703-670-1313 | |
Tieya Whites, CRNA Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 2300 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-523-2075 | |
Libby Oldenburg, Nurse Anesthetist - CR Medicare: May Accept Medicare Assignments Practice Location: 2300 Opitz Blvd, Woodbridge, VA 22191 Phone: 703-523-1000 |